Lucosky Brookman is the industry leader in “Uplisting” domestic or foreign quoted OTC companies and foreign exchange listed companies to the NASDAQ or NYSE. "Uplisting" is the global practice of elevating a company (foreign or domestic) from having its stock quoted on an alternative trading platform like the OTC Markets, TSX or the ASX, to the NASDAQ or NYSE. For micro or small cap companies to succeed in the Uplist process, they need to have more than just an attorney, they need an advocate, a leader, a quarterback to proactively usher the company through the process and across the finish line. For 11 years, the attorneys at Lucosky Brookman have successfully assisted numerous companies achieve their goals by completing successful listing transactions on the NASDAQ or NYSE – many times in connection with a simultaneous financing transaction.
"Joseph Lucosky and his team at Lucosky Brookman are the hardest working and most proactive attorneys I have ever dealt with in my professional career. For me, they were hands down the best choice when deciding to restructure my company and pursue an Uplisting from the OTC to the NASDAQ. His work ethic, judgment and advice are second to none. His mindset inspires confidence and respect from everyone even in the most stressful circumstances. Joseph's commitment to execution and not “lawyer talk” is refreshing and his unwavering commitment to results was superior to other attorneys I have worked with. I highly recommend Joseph and his team at Lucosky Brookman if you are a CEO that appreciates clear advice and a results-driven approach to this crazy micro/small-cap world. To put it plainly Joe and his team get results."
- Grant Johnson, Chief Executive Officer
Esports Entertainment Group, Inc. (NASDAQ: GMBL)
Successful 2020 Uplisting to NASDAQ and $8,400,000 Capital Raise
Trading and, more importantly, thriving on a national securities exchange is the ultimate goal of most microcap and small cap companies. Unless a company qualifies to undertake an initial public offering or a direct listing directly onto a national exchange, reaching this goal is accomplished by Uplisting. The potential benefits of Uplisting include, among many other benefits, increased marketplace attention, improved liquidity for existing shareholders and potential investors, ease of depositing shares, and improved availability of capital (including the possibility of doing an S-3 shelf takedown following the Uplist).
As is the case in many things in life, how you begin often dictates how you end up. The first step is the most important. For a microcap company to succeed in this process, the company must engage a competent team of professionals – each of whom has a track record of successfully bringing OTC companies to the next level. Typically, a competent attorney should quarterback the process – outlining the macro plan and keeping the team of professionals on track to meet each of the company’s micro objectives throughout the process. Without a strong leader at the helm, the Uplist transaction may never succeed.
|Preparation, Documentation & Registration|
|Quiet Period & Amendments|
|Pricing and Closing|
Listed below are some of the services that we provide to our clients:
In addition to our team’s highly-valued added services that we provide during the Uplisting process, we also handle the following projects and tasks from a legal perspective::
Lucosky Brookman is an industry leader in all types of legal representation with respect to the Uplist process:
"Our company, just successfully Uplisted from OTC to NASDAQ. We would not have been able to do so were it not for the Lucosky Brookman team who helped us each step of the way. I highly recommend Joseph Lucosky. He is a dedicated, professional and has an extremely hard-working team. There was not a moment that I doubted their commitment and their efforts led us to our eventual success. Thank you, Joe, Lawrence and your entire team."
Gianni Arcaini, CEO
Duos Technologies Group, Inc.
2020 Uplisting to NASDAQ and $8,100,000 Capital Raise